PAI1 has been used as a potential diagnostic marker for AD and cognitive function decline [38], showing that PAI1 was significantly different between the healthy control group, MCI group, and AD group within participants with a mean age of seventy−five [38]. This evidence concerns the gene SERPINE1 and Alzheimer disease.